187 related articles for article (PubMed ID: 15075746)
1. Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy.
Fishbein MC; Kobashigawa J
Curr Opin Cardiol; 2004 Mar; 19(2):166-9. PubMed ID: 15075746
[TBL] [Abstract][Full Text] [Related]
2. Contemporary concepts in noncellular rejection.
Kobashigawa JA
Heart Fail Clin; 2007 Jan; 3(1):11-5. PubMed ID: 17545005
[TBL] [Abstract][Full Text] [Related]
3. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.
Michaels PJ; Espejo ML; Kobashigawa J; Alejos JC; Burch C; Takemoto S; Reed EF; Fishbein MC
J Heart Lung Transplant; 2003 Jan; 22(1):58-69. PubMed ID: 12531414
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of humoral rejection after pediatric heart transplantation.
Zales VR; Crawford S; Backer CL; Lynch P; Benson DW; Mavroudis C
J Heart Lung Transplant; 1993; 12(4):563-71; discussion 572. PubMed ID: 8369319
[TBL] [Abstract][Full Text] [Related]
5. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients.
Lones MA; Czer LS; Trento A; Harasty D; Miller JM; Fishbein MC
J Heart Lung Transplant; 1995; 14(1 Pt 1):151-62. PubMed ID: 7727464
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of severe hemodynamic compromise in pediatric heart transplant patients.
Costello JM; Pahl E
Paediatr Drugs; 2002; 4(11):705-15. PubMed ID: 12390042
[TBL] [Abstract][Full Text] [Related]
7. Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment.
Mauiyyedi S; Colvin RB
Curr Opin Nephrol Hypertens; 2002 Nov; 11(6):609-18. PubMed ID: 12394606
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppression, diagnosis, and treatment of cardiac allograft rejection.
Patel JK; Kobashigawa JA
Semin Thorac Cardiovasc Surg; 2004; 16(4):378-85. PubMed ID: 15635544
[TBL] [Abstract][Full Text] [Related]
9. Effect of plasmapheresis for acute humoral rejection after heart transplantation.
Wang SS; Chou NK; Ko WJ; Chi NH; Hung SC; Hsu RB; Yu HY; Chen YS; Chu SH; Tsao CI; Shun CT
Transplant Proc; 2006 Dec; 38(10):3692-4. PubMed ID: 17175369
[TBL] [Abstract][Full Text] [Related]
10. Fulminant mixed humoral and cellular rejection in a cardiac transplant recipient: a review of the histologic findings and literature.
Book WM; Kelley L; Gravanis MB
J Heart Lung Transplant; 2003 May; 22(5):604-7. PubMed ID: 12742427
[TBL] [Abstract][Full Text] [Related]
11. Is biopsy-proven cellular rejection an important clinical consideration in heart transplantation?
Kirklin JK
Curr Opin Cardiol; 2005 Mar; 20(2):127-31. PubMed ID: 15711199
[TBL] [Abstract][Full Text] [Related]
12. Characterization of c4d immunostaining utilizing paraffin-embedded tissue of nonpresensitized pediatric heart transplant patients.
Galambos C; Feingold B; Webber SA
Pediatr Dev Pathol; 2008; 11(3):181-4. PubMed ID: 17990923
[TBL] [Abstract][Full Text] [Related]
13. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
[TBL] [Abstract][Full Text] [Related]
14. [Corticoid-resistant rejection and humoral rejection. The diagnostic criteria and therapeutic management].
Crespo Leiro MG; Portela Torrón F; Vázquez González N; Vázquez Rodríguez JM; Yebra Pimentel MT; González Cuesta M
Rev Esp Cardiol; 1995; 48 Suppl 7():77-85. PubMed ID: 8775821
[TBL] [Abstract][Full Text] [Related]
15. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies.
Behr TM; Feucht HE; Richter K; Reiter C; Spes CH; Pongratz D; Uberfuhr P; Meiser B; Theisen K; Angermann CE
J Heart Lung Transplant; 1999 Sep; 18(9):904-12. PubMed ID: 10528753
[TBL] [Abstract][Full Text] [Related]
16. The challenge of rejection and cardiac allograft vasculopathy.
Cotts WG; Johnson MR
Heart Fail Rev; 2001 Sep; 6(3):227-40. PubMed ID: 11391041
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
[TBL] [Abstract][Full Text] [Related]
18. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management.
Veiga Barreiro A; Crespo Leiro M; Doménech García N; Paniagua MJ; Vázquez Martul E; González Cuesta M; Ramírez C; Juffé Stein A; Castro Beiras A
Transplant Proc; 2004 Apr; 36(3):778-9. PubMed ID: 15110660
[TBL] [Abstract][Full Text] [Related]
19. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
[TBL] [Abstract][Full Text] [Related]
20. Posttransplant Pulmonary Hypertension Is Correlated With Acute Rejection and Death Among Cardiac Transplant Recipients: A Single Center Study.
Çiftci O; Akgün NA; Yılmaz KC; Karaçağlar E; Aydınalp A; Sezgin A; Müderrisoğlu IH; Haberal M
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):80-84. PubMed ID: 29527998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
